GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hill-Rom Holdings Inc (NYSE:HRC) » Definitions » Gross Profit

Hill-Rom Holdings (Hill-Rom Holdings) Gross Profit : $1,588 Mil (TTM As of Sep. 2021)


View and export this data going back to 1989. Start your Free Trial

What is Hill-Rom Holdings Gross Profit?

Hill-Rom Holdings's gross profit for the three months ended in Sep. 2021 was $427 Mil. Hill-Rom Holdings's gross profit for the trailing twelve months (TTM) ended in Sep. 2021 was $1,588 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Hill-Rom Holdings's gross profit for the three months ended in Sep. 2021 was $427 Mil. Hill-Rom Holdings's Revenue for the three months ended in Sep. 2021 was $798 Mil. Therefore, Hill-Rom Holdings's Gross Margin % for the quarter that ended in Sep. 2021 was 53.52%.

Hill-Rom Holdings had a gross margin of 53.52% for the quarter that ended in Sep. 2021 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Hill-Rom Holdings was 52.61%. The lowest was 44.28%. And the median was 47.74%.


Hill-Rom Holdings Gross Profit Historical Data

The historical data trend for Hill-Rom Holdings's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hill-Rom Holdings Gross Profit Chart

Hill-Rom Holdings Annual Data
Trend Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,320.60 1,394.20 1,425.00 1,475.10 1,588.10

Hill-Rom Holdings Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 356.90 379.20 407.40 374.50 427.00

Competitive Comparison of Hill-Rom Holdings's Gross Profit

For the Medical Instruments & Supplies subindustry, Hill-Rom Holdings's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hill-Rom Holdings's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hill-Rom Holdings's Gross Profit distribution charts can be found below:

* The bar in red indicates where Hill-Rom Holdings's Gross Profit falls into.



Hill-Rom Holdings Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Hill-Rom Holdings's Gross Profit for the fiscal year that ended in Sep. 2021 is calculated as

Gross Profit (A: Sep. 2021 )=Revenue - Cost of Goods Sold
=3018.7 - 1430.6
=1,588

Hill-Rom Holdings's Gross Profit for the quarter that ended in Sep. 2021 is calculated as

Gross Profit (Q: Sep. 2021 )=Revenue - Cost of Goods Sold
=797.9 - 370.9
=427

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,588 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Hill-Rom Holdings's Gross Margin % for the quarter that ended in Sep. 2021 is calculated as

Gross Margin % (Q: Sep. 2021 )=Gross Profit (Q: Sep. 2021 ) / Revenue (Q: Sep. 2021 )
=(Revenue - Cost of Goods Sold) / Revenue
=427 / 797.9
=53.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Hill-Rom Holdings  (NYSE:HRC) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Hill-Rom Holdings had a gross margin of 53.52% for the quarter that ended in Sep. 2021 => Durable competitive advantage


Hill-Rom Holdings Gross Profit Related Terms

Thank you for viewing the detailed overview of Hill-Rom Holdings's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Hill-Rom Holdings (Hill-Rom Holdings) Business Description

Traded in Other Exchanges
N/A
Address
130 East Randolph Street, Suite 1000, Chicago, IL, USA, 60601
Hill-Rom Holdings Inc is a global provider of hospital equipment and medical supplies, including hospital beds for high- and low-acuity settings. Hill-Rom reports financial data across three operating segments: patient support systems (50% of fiscal 2018 sales), front-line care (34%), and surgical solutions (16%). The firm has significant operations internationally, with roughly 30% of revenue derived from international sources and the remaining 70% from its U.S. business.
Executives
Mary Kay Ladone officer: SVP, Corp. Dev., Strat. & IR 130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601
Deborah Rasin officer: SVP, Chief Legal Officer TWO PRUDENTIAL PLAZA, SUITE 4100, CHICAGO IL 60601
Paul Sherwood Johnson officer: SVP & Pres. - PSS Acute Care TWO PRUDENTIAL PLAZA 180 NORTH STETSON AVENUE, SUITE 4100 CHICAGO IL 60601
Andreas G Frank officer: SVP, Pres. Front Line Care C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Richard M Wagner officer: Corporate Controller 221 WEST PHILADELPHIA STREET, SUITE 60W, YORK PA 17401-2991
Amy M. Dodrill officer: President - Surgical Solutions 130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601
Gary Lee Ellis director THE TORO COMPANY, 8111 LYNDALE AVENUE SOUTH, BLOOMINGTON MN 55420
Mary Garrett director ETHAN ALLEN DRIVE, DANBURY CT 06811
Gregory J. Moore director 130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601
William Kucheman director C/O DAN DUGAN, FINANCIAL PERSPECTIVES, 3025 HARBOR LN., SUITE 200, PLYMOUTH MN 55447
James R Giertz director
Ronald A Malone director 3 HUNTINGTON QUADRANGLE, SUITE 200S, MELVILLE NY 11747
Felicia F Norwood director 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
William G Dempsey director C/O LANDAUER, INC., 2 SCIENCE ROAD, GLENWOOD IL 60425
Nancy M Schlichting director 200 WILMOT ROAD, DEERFIELD IL 60015